⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8383685 | 1.00 | — | — | |
| SCHEMBL8383226 | 1.00 | — | — | |
| SCHEMBL14830959 | 1.00 | — | — | |
| SCHEMBL8388128 | 1.00 | — | — | |
| SCHEMBL1494542 | 1.00 | — | — | |
| SCHEMBL1494569 | 1.00 | — | — | |
| SCHEMBL5419185 | 0.94 | — | — | |
| SCHEMBL20606 | 0.94 | — | — | |
| SCHEMBL7746391 | 0.94 | — | — | |
| SCHEMBL4209624 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101170986-B | Hardenable dental compositions with low polymerization shrinkage | 3M INNOVATIVE PROPERTIES CO | 2011-07-27 | — | — | CN | claimed |
| CN-101052406-A | New use of super low molecular heparin | OUPCOIN COMMON S P A (IT) | 2007-10-10 | — | — | CN | claimed |
| CN-1767835-A | Compositions comprising cyclooxygenase-2 selective inhibitors and glucosamine for the treatment and prevention of pain and inflammation | PHARMACIA CORP (US) | 2006-05-03 | — | — | CN | claimed |
| CN-1575182-A | Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate | PHARMACIA CORP (US) | 2005-02-02 | — | — | CN | claimed |
| CN-1278297-A | Detergent compositions | PROCTER & GAMBLE (US) | 2000-12-27 | — | — | CN | claimed |
| CN-102245635-A | Modified variant bowman birk protease inhibitors | DANISCO US INC GENENCOR DIV | 2011-11-16 | — | — | CN | disclosed |
| CN-101278051-B | Personal care compositions and methods of use thereof | GENENCOR INT | 2011-10-05 | — | — | CN | disclosed |
| CN-101170986-B | Hardenable dental compositions with low polymerization shrinkage | 3M INNOVATIVE PROPERTIES CO | 2011-07-27 | — | — | CN | disclosed |
| US-20090232827-A1 | Compositions and methods of use of compounds to increase cancer patient survival time | BIONUMERIK PHARMACEUTICALS, INC. | 2009-09-17 | — | — | US | disclosed |
| US-20090118389-A1 | Hardenable dental compositions with low polymerization shrinkage | 3M INNOVATIVE PROPERTIES COMPANY | 2009-05-07 | — | — | US | disclosed |
| CN-101278051-A | Personal care compositions and methods of use thereof | GENENCOR INT (US) | 2008-10-01 | — | — | CN | disclosed |
| CN-101170986-A | Hardenable dental compositions with low polymerization shrinkage | 3M INNOVATIVE PROPERTIES CO (US) | 2008-04-30 | — | — | CN | disclosed |
| CN-1124495-A | Secondary (2,3) alkyl sulfate surfactants in high density granular detergent compositions | PROCTER & GAMBLE (US) | 1996-06-12 | — | — | CN | disclosed |
| CN-1124496-A | Secondary (2, 3) alkyl sulfate surfactants in stable enzyme-containing detergent compositions | PROCTER & GAMBLE (US) | 1996-06-12 | — | — | CN | disclosed |
| CN-1124497-A | Process for purifying secondary (2, 3) alkyl sulfate surfactants | PROCTER & GAMBLE (US) | 1996-06-12 | — | — | CN | disclosed |
| CN-1124498-A | Secondary (2,3) alkyl sulfate surfactants in mixed surfactant particles | PROCTER & GAMBLE (US) | 1996-06-12 | — | — | CN | disclosed |
| CN-1124494-A | Secondary (2,3) alkyl sulfate surfactants to coat free-flowing granular detergent compositions | PROCTER & GAMBLE (US) | 1996-06-12 | — | — | CN | disclosed |
| CN-1112122-A | Sulfated-glycolipid derivatives as cell adhesion inhibitors | BRISTOL MYERS SQUIBB CO (US) | 1995-11-22 | — | — | CN | disclosed |
| CN-1111638-A | Sulfated-glycolipid derivatives as cell adhesion inhibitors | BRISTOL MYERS SQUIBB CO (US) | 1995-11-15 | — | — | CN | disclosed |
| CN-1093904-A | Regulate the compositions of cytokine activity | YEDA RES & DEV (IL) | 1994-10-26 | — | — | CN | disclosed |